Anna Kernder

666 total citations
20 papers, 269 citations indexed

About

Anna Kernder is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Kernder has authored 20 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 8 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Kernder's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Systemic Sclerosis and Related Diseases (4 papers). Anna Kernder is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Systemic Sclerosis and Related Diseases (4 papers). Anna Kernder collaborates with scholars based in Germany, Italy and United States. Anna Kernder's co-authors include Matthias Schneider, Gamal Chehab, Jutta Richter, Ralph Brinks, B. Winkler-Rohlfing, Rebecca Fischer‐Betz, Martin Aringer, Olga A. Sergeeva, Johanna Mücke and Helmut L. Haas and has published in prestigious journals such as Annals of the Rheumatic Diseases, Neuropharmacology and Lara D. Veeken.

In The Last Decade

Anna Kernder

17 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kernder Germany 7 158 98 51 37 28 20 269
Howard Rossman United States 7 54 0.3× 66 0.7× 336 6.6× 32 0.9× 8 0.3× 9 403
Amy Perrin Ross United States 12 61 0.4× 66 0.7× 265 5.2× 33 0.9× 5 0.2× 35 425
Swamy Venuturupalli United States 11 87 0.6× 69 0.7× 16 0.3× 16 0.4× 2 0.1× 19 277
Reza Vosoughi Canada 9 55 0.3× 62 0.6× 194 3.8× 21 0.6× 5 0.2× 22 354
M Mosca Italy 8 315 2.0× 114 1.2× 118 2.3× 33 0.9× 2 0.1× 15 422
Alice Rutatangwa United States 11 32 0.2× 125 1.3× 267 5.2× 27 0.7× 10 0.4× 14 400
Maria Pedersen Norway 6 121 0.8× 48 0.5× 29 0.6× 21 0.6× 3 0.1× 14 281
James Simsarian United States 9 87 0.6× 68 0.7× 185 3.6× 19 0.5× 5 0.2× 13 316
Alexander Stahmann Germany 12 67 0.4× 30 0.3× 315 6.2× 26 0.7× 4 0.1× 38 395
F. Eggelmeijer Netherlands 11 167 1.1× 18 0.2× 23 0.5× 17 0.5× 5 0.2× 20 402

Countries citing papers authored by Anna Kernder

Since Specialization
Citations

This map shows the geographic impact of Anna Kernder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kernder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kernder more than expected).

Fields of papers citing papers by Anna Kernder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kernder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kernder. The network helps show where Anna Kernder may publish in the future.

Co-authorship network of co-authors of Anna Kernder

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kernder. A scholar is included among the top collaborators of Anna Kernder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kernder. Anna Kernder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Friedrich, R, Anna Kernder, Norbert Blank, et al.. (2024). Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany. Zeitschrift für Rheumatologie. 84(1). 30–38. 1 indexed citations
3.
Kernder, Anna, Marius Rohde, Hasan Acar, et al.. (2024). Patient-reported outcomes in large vessel vasculitis: insights from a retrospective analysis of disease activity and associated factors. Journal of Patient-Reported Outcomes. 8(1). 4–4.
4.
Kernder, Anna, K. Thiele, Gamal Chehab, Matthias Schneider, & Johanna Callhoff. (2023). Time interval between the onset of connective tissue disease symptoms and first contact with a rheumatologist: results from the German National Database of collaborative arthritis centers. Rheumatology International. 43(8). 1453–1458. 4 indexed citations
5.
Kernder, Anna, Kirsten de Groot, Bernhard Hellmich, et al.. (2023). COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey. Frontiers in Medicine. 9. 1103694–1103694. 2 indexed citations
6.
Rohde, Marius, Anna Kernder, Hasan Acar, et al.. (2023). Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis. Frontiers in Medicine. 10. 4 indexed citations
7.
8.
Richter, Jutta, Hasan Acar, Ellen Bleck, et al.. (2023). Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank. Frontiers in Medicine. 10. 1208006–1208006. 1 indexed citations
9.
Sergeeva, Olga A., et al.. (2021). Tachykinins amplify the action of capsaicin on central histaminergic neurons. Peptides. 150. 170729–170729. 3 indexed citations
10.
Kernder, Anna, Jutta Richter, Ralph Brinks, et al.. (2021). Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study. Lupus. 30(12). 1931–1937. 6 indexed citations
11.
12.
Kernder, Anna, Jutta Richter, Rebecca Fischer‐Betz, et al.. (2021). Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort. Lupus. 30(3). 431–438. 72 indexed citations
13.
Kernder, Anna, Harriet Morf, Philipp Klemm, et al.. (2021). Digital rheumatology in the era of COVID-19: results of a national patient and physician survey. RMD Open. 7(1). e001548–e001548. 70 indexed citations
14.
Kernder, Anna, Elena Elefante, Gamal Chehab, et al.. (2020). The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?. Lara D. Veeken. 59(Supplement_5). v63–v68. 31 indexed citations
15.
Kernder, Anna, Jutta Richter, Rebecca Fischer‐Betz, et al.. (2020). Quality of care predicts outcome in systemic lupus erythematosus: a cross-sectional analysis of a German long-term study (LuLa cohort). Lupus. 29(2). 136–143. 17 indexed citations
16.
Kernder, Anna, Johanna Mücke, Torsten Lowin, et al.. (2019). AB0125 CXCL17 IN RHEUMATOID ARTHRITIS: INTERFERONE-GAMMA INDUCIBLE EXPRESSION AND INHIBITION OF ANGIOGENESIS. Annals of the Rheumatic Diseases. 78. 1523–1523. 1 indexed citations
17.
Kernder, Anna, Jutta Richter, Rebecca Fischer‐Betz, et al.. (2019). OP0308 QUALITY OF CARE PREDICTS OUTCOME IN SYSTEMIC LUPUS ERYTHEMATOSUS – CROSS SECTIONAL ANALYSIS OF A GERMAN LONG-TERM STUDY (LULA COHORT, 2011–2015). Annals of the Rheumatic Diseases. 78. 236–236.
18.
Luca, Roberto De, Anna Kernder, Tatsiana Suvorava, et al.. (2018). Mechanisms of N-oleoyldopamine activation of central histaminergic neurons. Neuropharmacology. 143. 327–338. 9 indexed citations
19.
Kernder, Anna, Roberto De Luca, Yevgenij Yanovsky, Helmut L. Haas, & Olga A. Sergeeva. (2014). Acid-Sensing Hypothalamic Neurons Controlling Arousal. Cellular and Molecular Neurobiology. 34(6). 777–789. 10 indexed citations
20.
Yanovsky, Yevgenij, Jeffrey M. Zigman, Anna Kernder, et al.. (2012). Proton- and ammonium-sensing by histaminergic neurons controlling wakefulness. Frontiers in Systems Neuroscience. 6. 23–23. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard Rossman Breakdown of academic impact, for papers by Amy Perrin Ross Breakdown of academic impact, for papers by Swamy Venuturupalli Breakdown of academic impact, for papers by Reza Vosoughi Breakdown of academic impact, for papers by M Mosca Breakdown of academic impact, for papers by Alice Rutatangwa Breakdown of academic impact, for papers by Maria Pedersen Breakdown of academic impact, for papers by James Simsarian Breakdown of academic impact, for papers by Alexander Stahmann Breakdown of academic impact, for papers by F. Eggelmeijer
Rankless by CCL
2026